Trial Profile
A Phase I PK/PD Study of Lipegfilgrastim in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jun 2014
Price :
$35
*
At a glance
- Drugs Lipegfilgrastim (Primary)
- Indications Neutropenia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Teva Pharmaceutical Industries
- 24 Jun 2014 New trial record